Videocapsule Endoscopy for Gastrointestinal Bleeding
Trial Summary
What is the purpose of this trial?
This trial tests if using a small camera pill when an initial test fails to find bleeding in patients can improve outcomes. It aims to help doctors find hidden bleeding sources more quickly and comfortably, potentially reducing hospital stays and costs.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Videocapsule Endoscopy for gastrointestinal bleeding?
Research shows that videocapsule endoscopy is highly effective in identifying the source of obscure gastrointestinal bleeding and is recommended as the first choice for diagnosing small bowel bleeding. It has a high diagnostic yield, meaning it is very good at finding the cause of bleeding, which can help doctors decide on the best treatment.12345
Is videocapsule endoscopy safe for humans?
How does videocapsule endoscopy differ from other treatments for gastrointestinal bleeding?
Videocapsule endoscopy is unique because it is a non-invasive procedure that allows for a complete examination of the small bowel, which is often difficult to reach with traditional methods. Unlike other treatments, it involves swallowing a small capsule with a camera that captures images of the digestive tract, making it a first-line option for diagnosing small bowel bleeding.39101112
Eligibility Criteria
This trial is for adults over 18 who are stable after a new episode of upper gastrointestinal bleeding, evidenced by dark stools or a significant drop in hemoglobin. They must have had an initial negative gastroscopy and be able to consent. It's not for those with prior abdominal radiation, Crohn's disease, small bowel surgery or strictures, language barriers affecting consent, or pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Diagnostic
Participants undergo initial gastroscopy to confirm negative results for upper gastrointestinal bleeding
Early Small Bowel Investigation
Participants in the experimental group undergo videocapsule endoscopy immediately after negative gastroscopy
Colonoscopy
Participants in the active comparator group undergo bowel preparation and colonoscopy the next day after negative gastroscopy
Follow-up
Participants are monitored for safety and effectiveness after diagnostic procedures
Treatment Details
Interventions
- Videocapsule Endoscopy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor